SCHEMBL28978575

SCHEMBL28978575

O=S(=O)(Oc1ccnc(C2(F)CC2)c1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ HSD11B1 P28845 1/20 0.34
▸ HTR1D P28221 5/20 0.33
▸ CHRM1 P11229 5/20 0.33
▸ DRD2 P14416 5/20 0.33
▸ DRD3 P35462 5/20 0.33
▸ HTR1A P08908 4/20 0.33
▸ HTR1B P28222 4/20 0.33
▸ DRD4 P21917 4/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ PDE4A P27815 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15720571 0.73 LOXL2 (0.42) CA1CA2HSD11B1HTR1DHTR1A
SCHEMBL11945522 0.73 CA1 (0.40) CA1CA2HSD11B1HTR1DCHRM1
SCHEMBL17310149 0.73 CA1 (0.40) CA1CA2HSD11B1HTR1DCHRM1
SCHEMBL23674532 0.71 CA1 (0.39) CA1CA2HSD11B1HTR1DCHRM1
SCHEMBL28741515 0.70 HTR1D (0.40) CA1CA2HSD11B1HTR1DCHRM1
SCHEMBL28741615 0.70 RIPK2 (0.41) CA1CA2HSD11B1HTR1DCHRM1
SCHEMBL30384914 0.69 PDE4A (0.41) CA1CA2HSD11B1HTR1DCHRM1
SCHEMBL5308131 0.68 CA2 (0.42) CA1CA2HSD11B1HTR1DDRD2
SCHEMBL22836850 0.67 CA2 (0.37) CA1CA2HSD11B1HTR1DDRD2
SCHEMBL31032217 0.67 KDM4C (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916778-A Methionine adenosyltransferase inhibitor, preparation method and application thereof 赛诺哈勃药业(成都)有限公司 2023-04-04 — — CN disclosed
WO-2022053022-A1 METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 赛诺哈勃药业(成都)有限公司 2022-03-17 — — WO disclosed
Send feedback